12 October 2017
The information in this section is about medicines and has been written for health professionals.
- Advertising cosmetic injections
A brochure containing information on advertising cosmetic injections and complying with therapeutic goods legislation
- Advertising cosmetic services that include schedule 4 substances
Points for medical practitioners and cosmetic / beauty therapists to consider when advertising cosmetic services that involve therapeutic goods containing Schedule 4 substances
- Advertising health services with schedule 3, schedule 4 or schedule 8 medicines
Information for health professionals to consider when advertising health services that involve therapeutic goods containing schedule 3, schedule 4 or schedule 8 substances
- Advertising of vaccination services
Information for immunisation service providers regarding the advertising of the 2016 seasonal influenza vaccination services
- Australian Public Assessment Reports for prescription medicines (AusPARs)
An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application
- Availability of morphine sulfate injection products: Information for health professionals
All strengths of DBL Morphine Sulfate Injection products are in limited supply due to manufacturing issues resulting in delays to packaging.
- Black Triangle Scheme
The Black Triangle Scheme provides a simple means for practitioners and patients to identify certain types of new prescription medicines, and to encourage the reporting of adverse events associated with their use
- Cough and cold medicines for children - changes
Advice to consumers and health professionals on cough and cold medicines for children
- Labelling changes: information for health professionals
Information for health professionals about changes to medicine labels
- Medicines and TGA classifications
Australia has a two-tiered system for the regulation of medicines, including complementary medicines
- Prescribing medicines in pregnancy database
This database is intended to provide information to health professionals planning the medical management of pregnant patients or patients intending to become pregnant. It is not presented as medical advice to health professionals or the public.
- Product Information (PI)
A Product Information document (PI) provides health professionals with a summary of the scientific information relevant to the safe and effective use of a prescription or pharmacist-only medicine
- Registration of medicines for the medical termination of early pregnancy
The TGA has included Mifepristone (RU 486) on the Australian Register of Therapeutic Goods (ARTG) as of 29 August 2012
- What are 'therapeutic goods'?
Many of us use medicines or medical devices in our daily lives